Literature DB >> 26340091

Two Novel HOGA1 Splicing Mutations Identified in a Chinese Patient with Primary Hyperoxaluria Type 3.

Xinsheng Wang, Xiangzhong Zhao, Xiaoling Wang, Jian Yao, Feifei Zhang, Yanhua Lang, Sylvie Tuffery-Giraud, Irene Bottillo, Leping Shao.   

Abstract

BACKGROUND: Twenty-six HOGA1 mutations have been reported in primary hyperoxaluria (PH) type 3 (PH3) patients with c.700 + 5G>T accounting for about 50% of the total alleles. However, PH3 has never been described in Asians.
METHODS: A Chinese child with early-onset nephrolithiasis was suspected of having PH. We searched for AGXT, GRHPR and HOGA1 gene mutations in this patient and his parents. All coding regions, including intron-exon boundaries, were analyzed using PCR followed by direct sequence analysis.
RESULTS: Two heterozygous mutations not previously described in the literature about HOGA1 were identified (compound heterozygous). One mutation was a successive 2 bp substitution at the last nucleotide of exon 6 and at the first nucleotide of intron 6, respectively (c.834_834 + 1GG>TT), while the other one was a guanine to adenine substitution of the last nucleotide of exon 6 (c.834G>A). Direct sequencing analysis failed to find these mutations in 100 unrelated healthy subjects and the functional role on splicing of both variants found in this study was confirmed by a minigene assay based on the pSPL3 exon trapping vector. In addition, we found a SNP in this family (c.715G>A, p.V239I). There were no mutations detected in AGXT and GRHPR.
CONCLUSION: Two novel HOGA1 mutations were identified in association with PH3. This is the first description and investigation on mutant gene analysis of PH3 in an Asian.
© 2015 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26340091     DOI: 10.1159/000439232

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  7 in total

1.  Eleven novel SLC12A1 variants and an exonic mutation cause exon skipping in Bartter syndrome type I.

Authors:  Yue Han; Xiangzhong Zhao; Sai Wang; Cui Wang; Dongxu Tian; Yanhua Lang; Irene Bottillo; Xinsheng Wang; Leping Shao
Journal:  Endocrine       Date:  2019-02-21       Impact factor: 3.633

2.  Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.

Authors:  Xiaoliang Fang; Lei He; Guofeng Xu; Houwei Lin; Maosheng Xu; Hongquan Geng
Journal:  Pediatr Nephrol       Date:  2019-05-23       Impact factor: 3.714

3.  HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients.

Authors:  Saoussen M'dimegh; Cécile Aquaviva-Bourdain; Asma Omezzine; Geneviéve Souche; Ibtihel M'barek; Kamel Abidi; Tahar Gargah; Saoussen Abroug; Ali Bouslama
Journal:  J Clin Lab Anal       Date:  2016-08-26       Impact factor: 2.352

4.  Two novel AGXT mutations identified in primary hyperoxaluria type-1 and distinct morphological and structural difference in kidney stones.

Authors:  Cui Wang; Jingru Lu; Yanhua Lang; Ting Liu; Xiaoling Wang; Xiangzhong Zhao; Leping Shao
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

5.  A novel mutation in exon 9 of Cullin 3 gene contributes to aberrant splicing in pseudohypoaldosteronism type II.

Authors:  Leping Shao; Li Cui; Jingru Lu; Yanhua Lang; Irene Bottillo; Xiangzhong Zhao
Journal:  FEBS Open Bio       Date:  2018-02-10       Impact factor: 2.693

6.  A recurrent deletion in the SLC5A2 gene including the intron 7 branch site responsible for familial renal glucosuria.

Authors:  Xiangzhong Zhao; Li Cui; Yanhua Lang; Ting Liu; Jingru Lu; Cui Wang; Sylvie Tuffery-Giraud; Irene Bottillo; Xinsheng Wang; Leping Shao
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

7.  Genetic Variation of Migration Inhibitory Factor Gene rs2070766 Is Associated With Acute Coronary Syndromes in Chinese Population.

Authors:  Jin-Yu Zhang; Qian Zhao; Fen Liu; De-Yang Li; Li Men; Jun-Yi Luo; Ling Zhao; Xiao-Mei Li; Xiao-Ming Gao; Yi-Ning Yang
Journal:  Front Genet       Date:  2022-01-03       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.